Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii

Microbial Pathogenesis

Volumn 96, Issue , 2016, Pages 20-25

  Zhang, Xiaojiao ^a   Yang, Tianxiang ^a   Cao, Ju ^a   Sun, Jide ^a   Dai, Wei ^a   Zhang, Liping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

A. Baumannii; Protein; Vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; OUTER MEMBRANE PROTEIN A; RECOMBINANT PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; SUBUNIT VACCINE;

ACINETOBACTER INFECTION; ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL STRAIN; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; INFECTION PREVENTION; MOLECULAR CLONING; MOUSE; MULTIDRUG RESISTANCE; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVIEW; WESTERN BLOTTING; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMAL; BLOOD; DISEASE MODEL; HUMAN; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MUCOSAL DRUG ADMINISTRATION; MUCOSAL IMMUNITY; SURVIVAL ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, MUCOSAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BLOOD; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, MUCOSAL; MICE; SURVIVAL ANALYSIS; VACCINES, SUBUNIT;

EID: 84964932890     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.04.019     Document Type: Review

References (34)

1. Seifert H., Baginski R., Schulze A., Pulverer G. The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol. 1993, 279:544-552.
2. Nemec A., Janda L., Melter O., Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant A. baumannii isolates in the Czech Republic. J. Med. Microbiol. 1999, 48:287-296.
3. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. Global challenge of multidrug-resistant A. baumannii. Antimicrob. Agents Chemother. 2007, 51:3471-3484.
4. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant A. baumannii. J. Antimicrob. Chemother. 2010, 65:233-238.
5. Doi Y., Husain S., Potoski B.A., McCurry K.R., Paterson D.L. Extensively drug-resistant A. baumannii. Emerg. Infect. Dis. 2009, 15:980-982.
6. Lautenbach E., Synnestvedt M., Weiner M.G., Bilker W.B., Vo L., Schein J., et al. Epidemiology and impact of imipenem resistance in A. baumannii. Infect. Control Hosp. Epidemiol. 2009, 30:1186-1192.
7. Sunenshine R.H., Wright M.O., Maragakis L.L., Harris A.D., Song X., Hebden J., et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 2007, 13:97-103.
8. Falagas M.E., Rafailidis P.I., Matthaiou D.K., Virtzili S., Nikita D., Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and A. baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 2008, 32:450-454.
9. Gordon N.C., Wareham D.W. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant A. baumannii with tigecycline. J. Antimicrob. Chemother. 2009, 63:775-780.
10. Munoz-Price L.S., Zembower T., Penugonda S., Schreckenberger P., Lavin M.A., Welbel S., et al. Clinical outcomes of carbapenem-resistant A. baumannii bloodstream infections: study of a 2-State monoclonal outbreak. Infect. Control Hosp. Epidemiol. 2010, 31:1057-1062.
11. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., et al. Resistance to colistin in A. baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 2009, 53:3628-3634.
12. Park Y.K., Jung S.I., Park K.H., Cheong H.S., Peck K.R., Song J.H., et al. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol. Infect. Dis. 2009, 64:43-51.
13. Livermore D.M., Hill R.L., Thomson H., Charlett A., Turton J.F., Pike R., et al. Antimicrobial treatment and clinical outcome for infections with carbapenemand multiply-resistant A. baumannii around London. Int. J. Antimicrob. Agents 2010, 35:19-24.
14. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Aricò B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
15. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 2005, 309:148-150.
16. Luo Guanpingshen, Lin Lin, Ibrahim Ashraf S., Baquir Beverlie, Pantapalangkoor Paul, Bonomo Robert A., Doi Yohei, Adams Mark D., et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One 2012, 7:e29446.
17. Moriel D.G., Beatson S.A., Wurpel D.J., Lipman J., Nimmo G.R., Paterson D.L., et al. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS One 2013, 8:e77631.
18. Lin L., Tan B., Pantapalangkoor P., Ho T., Hujer A.M., Taracila M.A., et al. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 2013, 31:313-318.
19. McConnell M.J., Rumbo C., Bou G., Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011, 29:5705-5710.
20. Dai W., Huang S., Sun S., Cao J., Zhang L. Nosocomial spread of carbapenem-resistant A. baumannii (types ST75 and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital. Infect. Genet. Evol. 2013, 14:98-101.
21. Vaneechoutte M., Dijkshoorn L., Tjernberg I., Elaichouni A., de Vos P., Claeys G. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 1995, 33:11-15.
22. Lindahl G., Stalhammar-Carlemalm M., Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 2005, 18:102-127.
23. Courtney H.S., Dale J.B., Hasty D.L. Handbook of Bacterial Adhesion: Principles,Methods and Applications 2002, 553-579. Human Press, Totowa, NJ. Y.N. An, R.J. Friedman (Eds.).
24. Lin J., Huang S., Zhang Q. Outer membrane proteins: key players for bacterial adaptation in host niches. Microbes Infect. 2002, 4:325-331.
25. Niemann H.H., Schubert W.D., Heinz D.W. Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect. 2004, 6:101-112.
26. Ton-That H., Marraffini L.A., Schneewind O. Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim. Biophys. Acta 2004, 1694:269-278.
27. Janulczyk R., Rasmussen M. Improved pattern for genome-based screening identifies novel cell wall-attached proteins in gram-positive bacteria. Infect. Immun. 2001, 69:4019-4026.
28. Lee J.S., Lee J.C., Lee C.M., Jung I.D., Jeong Y.I., Seong E.Y., et al. Outer membrane protein A of A. baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem. Pharmacol. 2007, 74:86-97.
29. Jin J.S., Kwon S.O., Moon D.C., Gurung M., Lee J.H., Kim S.I., et al. A. baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One 2011, 6:e17027.
30. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N. Engl. J. Med. 2008, 358:1271-1281.
31. Jones A., Morgan D., Walsh A., Turton J., Livermore D., Pitt T., et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect. Dis. 2006, 6:317-318.
32. Sengstock D.M., Thyagarajan R., Apalara J., Mira A., Chopra T., Kaye K.S. Multidrug-Resistant A. baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis. 2010, 50:1617-1618.
33. McConnell Michael J., Pachón Jerónimo Active and passive immunization against A. baumannii using an inactivated whole cell vaccine. Vaccine 2011, 29:1-5.
34. McConnell M.J., Domínguez-Herrera J., Smani Y., López-Rojas R., Docobo-Pérez F., Pachón J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant A. baumannii. Infect. Immun. 2011, 79:518-526.